德国社区精神卫生保健项目GBV对严重精神疾病患者的效果与成本效果:随机对照试验研究方案
主要结局为自我报告赋权改善,次要结局包括治疗满意度、主观生活质量、未满足需求及成本效果比等,随访2年共5次评估。
要点
- GBV整合社区精神卫生团队、灵活Assertive社区治疗及危机干预服务。
- 采用初始标准化评估赋权、未满足需求及心理社会功能以确认纳入指征。
- 主要结局为自我报告赋权改善,随访2年共5次评估。
核心结论
- 研究结果预期提供GBV是否改善德国精神卫生保健供给的信息,并显示其能否克服既往研究指出的德国整合照护项目弱点。
主要发现
- 主要结局为自我报告赋权改善;次要结局包括治疗满意度、主观生活质量、未满足需求、疾病相关临床与社会功能损害及成本效果比。
- 同时研究GBV对非正式照护者负担和生活质量的影响。
关键数值与推荐
- 研究资格基于初始评估结果确定的GBV指征。
- 成本效果分析从法定健康保险和国民经济两个视角进行。
临床怎么用
- 若GBV有效,可为严重精神疾病患者提供整合社区照护模式,并支持基于标准化评估的照护需求确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The community-based mental health care programme GBV is based on the British Community Mental Health Teams and the Dutch Flexible Assertive Community Treatment model. In addition, the programme offers crisis-intervention services. A special feature of this integrated care programme is the initial standardised assessment process regarding empowerment, unmet care needs, and psychosocial functioning, used to verify the need for such a comprehensive form of care. The project evaluates the assessment process and analyses the effectiveness and cost-effectiveness of GBV compared to treatment as usual. METHODS: This randomised, controlled study includes five assessments over 2 years. In twelve regions in Germany, 1000 patients with severely impaired psychosocial functioning and unmet care needs will be recruited. Study eligibility relies on an indication for GBV based on the results of the initial assessment. The primary outcome is improved self-reported empowerment. Further outcomes include improved treatment satisfaction and subjective quality of life, reductions in patients' unmet needs and illness-related clinical and social impairment, and an improved cost-effectiveness ratio of the resources used (from the perspectives of both statutory health insurance and the national economy). In addition, the GBV's effects on the burden and quality of life of informal caregivers of patients will be investigated. DISCUSSION: The study's results are expected to provide information on whether the community-based mental health care programme GBV contributes to improving mental health care provision in Germany. In addition, the study will show whether the GBV successfully overcomes the weaknesses that former research has identified regarding a German integrated care programme. Such improvement is particularly expected with respect to the semi-structured assessment within GBV. TRIAL REGISTRATION: German Clinical Trial Register, DRKS00019086 . Registered on 3 January 2020.
引用
- Mueller-Stierlin AS, Meixner F, Kohlmann A, et al. Effectiveness and cost-effectiveness of a community-based mental health care programme (GBV) for people with severe mental illness in Germany: study protocol for a randomised controlled trial. Trials. 2020. PMID: 32605585. doi:10.1186/s13063-020-04492-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。